Elliott A Gruskin

USPTO Granted Patents = 41 (Patent Applications = 15)

CIPO Patents = 15 (Patent Applications = 7)

EPO Patents = 15 (Patent Applications = 8)

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 537(Granted Patents)

Location History:

East Norwalk, CT (US) (1996)
Killingsworth, CT (US) (2001 - 2002)
Killington, CT (US) (2012)
Killingworth, CT (US) (1996 - 2017)
West Chester, PA (US) (2017)
Malvern, PA (US) (2011 - 2023)

Company Filing History:

14 out of 1,184

United States Surgical Corporation

patents

14 out of 90

Acorda Therapeutics, Inc.

patents

8 out of 2,686

Depuy Synthes Products, Inc.

United States Surgical Corp. a Division of Tyco Healthcare Group

Mayo Foundation for Medical Education and Research

patents

8. 3 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2023

Loading Chart...

Areas of Expertise:

Inflatable Grow Tent

Photobioreactor

Bioresorbable Metal Implants

Stem Cell Activation

Neuronal Outgrowth

CNS Remyelination

Drug-Impregnated Encasement

Proteoglycan Degrading Mutants

Bioabsorbable Polymers

Biocompatible Medical Devices

Infection-Resistant Surgical Devices

Wound Treatment

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11641809 - Inflatable grow tent with integrated lighting (2023-05-09),

2. 11240977 - Compact photobioreactor with built-in lights (2022-02-08),

3. 11141467 - Methods of reducing extravasation of inflammatory cells (2021-10-12),

4. 10814112 - Drug-impregnated encasement (2020-10-27),

5. 10653463 - Controlling the degradation of bioresorbable metal implants (2020-05-19),

6. 10494604 - Method and device for activating stem cells (2019-12-03),

7. 10039580 - Controlling the degradation of bioresorbable metal implants (2018-08-07),

8. 9956273 - Compositions and methods for promoting neuronal outgrowth (2018-05-01),

9. 9839679 - Methods of reducing extravasation of inflammatory cells (2017-12-12),

10. 9751943 - Compositions and methods including a recombinant human MAB that promotes CNS remyelination (2017-09-05),

11. 9579260 - Drug-impregnated encasement (2017-02-28),

12. 9528102 - Proteoglycan degrading mutants for treatment of CNS (2016-12-27),

13. 9468671 - Compositions and methods for promoting neuronal outgrowth (2016-10-18),

14. 8906363 - Fusion proteins for the treatment of CNS (2014-12-09),

15. 8900620 - Drug-impregnated encasement (2014-12-02),

Title: The Innovative Journey of Elliott A. Gruskin

Introduction: Elliott A. Gruskin, a distinguished inventor hailing from Malvern, PA, has made significant contributions to the world of technology and innovation.

Latest Patents: Elliott A. Gruskin holds several groundbreaking patents in the fields of electronics and telecommunications, showcasing his prowess in creating cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Elliott A. Gruskin has worked tirelessly to push the boundaries of technological advancements, earning a reputation as a visionary in his field.

Collaborations: Throughout his career, Elliott A. Gruskin has collaborated with leading tech companies and research institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: Elliott A. Gruskin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs in the ever-evolving tech landscape.

This text is generated by artificial intelligence and may not be accurate.